AI Sentiment: Bullish
Reason: Cannabis International Holdings, Inc. (CBIH) is working to advocate for the medical benefits of marijuana and supports the inclusion of a young medical marijuana patient as a witness in a hearing about rescheduling the drug. This could impact future legislation positively.
The Cannabis International Holdings, Inc. (CBIH) recently submitted a petition to include Alexis Bortell, a 13-year-old medical marijuana patient, as a witness in a hearing about rescheduling marijuana within the Controlled Substances Act. This step was taken in response to the Drug Enforcement Administration's (DEA) recent motion to dismiss a lawsuit initiated by a group of medical marijuana patients and advocates.
The inclusion of Bortell as a witness is crucial as she uses cannabis for medical reasons. At the tender age of seven, Bortell was diagnosed with epilepsy. Traditional medication did not provide sufficient relief from her seizures, which led her family to explore alternative treatments. After moving to Colorado, a state where medical marijuana is legal, Bortell began using a strain of cannabis oil known as 'Haleigh's Hope.' Since then, she has been seizure-free for over five years.
The DEA currently classifies marijuana as a Schedule I drug, implying that it has no accepted medical use and a high potential for abuse. However, Bortell's case represents a significant challenge to this classification. The CBIH, a proponent for the medicinal benefits of cannabis, strongly supports her inclusion as a witness in the upcoming hearing.
The CBIH has been actively working to ensure that the voices of patients who benefit from medical marijuana are heard. The company believes that Bortell's testimony could have a profound impact on the hearing and on future marijuana legislation. It is a clear example of how cannabis can provide significant relief to patients suffering from chronic conditions where traditional treatments have failed.
The petition to include Bortell as a witness is seen as a significant move in the fight for federal legalization of marijuana for medicinal purposes. The outcome of the hearing could potentially impact the future of medical marijuana laws across the United States, and the inclusion of Bortell's testimony could provide compelling evidence of the drug's medical benefits.